Active substanceBendazole + Metamizol sodium + Papaverine + PhenobarbitalBendazole + Metamizol sodium + Papaverine + Phenobarbital
Similar drugsTo uncover
  • Andipal
    pills inwards 
  • Andipal
    pills inwards 
    DALHIMFARM, OJSC     Russia
  • Andipal
    pills inwards 
  • Andipal
    pills inwards 
  • Andipal
    pills inwards 
    IRBITSK HFZ, OJSC     Russia
  • Andipal
    pills inwards 
  • Andipal
    pills inwards 
    URALBIOFARM, OJSC     Russia
  • Andipal
    pills inwards 
  • Andipal Avexima
    pills inwards 
    ASFARMA, LLC     Russia
  • Dosage form: & nbspPills.
    Composition:
    Active substances: metamizole sodium (analgin) - 250 mg; phenobarbital - 20 mg;
    Bendazole - 20 mg; papaverine hydrochloride 20 mg.
    Excipients: potato starch - 51.84 mg; talc - 4.6 mg; stearic acid - 3.56 mg.
    Description:
    Tablets are white or white with a yellowish hue of color, flat-cylindrical shape, with a facet and a risk.
    Pharmacotherapeutic group:Analgesic agent (analgesic non-narcotic agent + antispasmodic drug + barbiturate).
    ATX: & nbsp

    N.02.B.B.52   Metamizole sodium in combination with other drugs, excluding psycholeptics

    Pharmacodynamics:

    Combined drug, it has a vasodilating, analgesic and antispasmodic effect.

    Reducing the overall peripheral resistance, acting on arterioles, the drug lowers blood pressure, improves collateral circulation, increases the delivery of oxygen to the heart.

    Metamizole sodium has analgesic, antipyretic and weak anti-inflammatory effect. Combination of antispasmodics (benzazole and papaverine hydrochloride) with metamizole sodium enhances the analgesic effect of the latter with headache, migraine. The presence of phenobarbital in the preparation promotes the manifestation of sedative affect and the intensification of the action of other components.

    Indications:

    Pain syndrome associated with spasm of the peripheral arteries, smooth muscles of the gastrointestinal tract. vessels of the brain; arterial hypertension.

    Contraindications:

    Hypersensitivity, severe hepatic and renal insufficiency, myasthenia gravis, pregnancy (especially the first trimester), lactation period, blood diseases, hypotension, glaucoma.

    Dosing and Administration:

    Inside, 1 tablet 2-3 times a day.

    The duration of the application without consulting a doctor should not exceed 7 days.

    Side effects:

    Allergic reactions, drowsiness, nausea, constipation, decreased speed of psychomotor reactions; with prolonged use: a violation of the liver and kidneys, leukopenia, agranulocytosis.

    Interaction:

    Combination with nitrates (nitroglycerine, nitrosorbide, suture, etc.), blockers of Ca-channels (nifedipine, Corinfar, etc.), beta-blockers (anaprilin, metoprolol, talinolol and others), ganglion blockers (pentamine, etc.), diuretics (furosemide, hypothiazide, etc.), myotropic antispasmodics (dipyridamole, eufillin, etc.) enhances the hypotensive effect of the drug.

    Simultaneous use with other non-narcotic analgesics can lead to mutual enhancement of toxic effects.

    Joint application with adsorbents, astringents and enveloping agents reduces the absorption of the drug in the gastrointestinal tract.

    Special instructions:

    At long (more than 7 days) application control of a picture of peripheric blood and a functional status of a liver is necessary.

    Effect on the ability to drive transp. cf. and fur:During treatment it is necessary to refuse employment by potentially dangerous kinds of activity,requiring increased concentration of attention and speed of psychomotor reactions.
    Form release / dosage:
    Pills.
    Packaging:For 10 tablets in a contour cell or cellulose package.
    1, 2, or 5 or contour of cellular bezgyachakova packaging together with instructions for use placed in a pile of cardboard boxed.
    Outlined Valium Valium or packaging together with an equal number of instructions for use are placed in multipacks.
    Storage conditions:
    In the dark place at a temperature of no higher than 25 ° C.
    Keep out of the reach of children.
    Shelf life:

    2 years and 6 months. The drug should not be used after the expiration date.

    Terms of leave from pharmacies:Without recipe
    Registration number:LS-002055
    Date of registration:28.06.2010
    The owner of the registration certificate:PHARMSTANDART-TOMSKHIMFARM, OJSC PHARMSTANDART-TOMSKHIMFARM, OJSC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp15.11.2012
    Illustrated instructions
      Instructions
      Up